Preprint2024
Effect of Breathing Phase Number on the 4D Robust Optimization for Pancreatic Cancer Intensity Modulated Proton Therapy
- Published
- 16 September 2024
- Citations
- 0
- Type
- Preprint
- License
- cc by
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by
Abstract Purpose Respiratory movement, as one of the main challenges in proton therapy for pancreatic cancer patients, could not only lead to harm to normal tissues but also lead to failure of the tumor control, resulting in irreversible consequences. Including respiratory movements into the plan optimization, i.e. 4D robust optimization, may mitigate the interplay effect. However, 4D robust optimization considering images of all breathing phases is time-consuming and less efficient. This work aims to investigate the effect of the breathing phase number on the 4D robust optimization for pancreatic cancer intensity modulated proton therapy (IMPT) by examining plan quality and computational efficiency. Methods A total of 15 pancreatic cancer patients were retrospectively analyzed. For each patient, five four-dimensional (4D) robust treatment planning strategies with different numbers of respiratory phases and one three-dimensional (3D) treatment plan were created. Optimization of the plans were performed on all ten phases (10phase plan), two extreme phases (2phase plan), two extreme phases plus an intermediate state (3phase plan), six phases during the exhalation stage (6Exphase plan), six phases during the inhalation stage (6Inphase plan) and 3D Computed Tomography (CT) scan image (3D plan), respectively. 4D dynamic dose (4DDD) was then calculated to access the interplay effect by considering respiratory motion and dynamic beam delivery. Plan quality and dosimetric parameters for the target and organs at risk (OARs) were then analyzed. Results Compared to the 4D plans, 3D plan only showed lower maximum dose of the small intestine while performing worse on all other aspects. All five 4D treatment planning strategies showed similar protection of the OARs. Both the 6Exphase and 6Inphase plans demonstrated similar performance as the 10phase plan in target coverage, outperforming the other three plans. Compared with the 10phase plan, the average decline rates of the optimization time of the five plans of 2phase, 3phase, 6Exphase, 6Inphase, and 3D were 73.26 ± 6.54%, 65.80 ± 7.89%, 42.14 ± 13.57%, 37.72 ± 11.70% and 75.52 ± 8.21%, respectively. With the decrease of the number of phases selected for optimization, the decline rates increased, while the other dosimetry parameters generally showed a deterioration trend. Conclusion This study highlighted that the dosimetric performances of the 6Exphase and 6Inphase plans closely aligned with that of the 10phase plan. These plans offered a feasible alternative to 10phase optimization by reducing optimization time while maintaining dose coverage of the target and protection of OARs.